Lisa A. Newman, M.D., M.P.H., director of the Breast Care Center, is one of seven University of Michigan faculty members to receive the 2015 Harold R. Johnson Diversity Service Award from the Office of the Provost.
A new study finds that many women diagnosed with breast cancer are concerned about the genetic risk of developing other cancers themselves or of a loved one developing cancer.
A new study provides direct evidence for the role of the Notch pathway in breast cancer stem cell activity as demonstrated by a Notch reporter system. Notch signaling regulates embryonic and tissue-specific stem cells, which are altered in a number of cancers, including breast cancer.
A new study characterizes the genetic underpinnings of a rare type of breast tumor called phyllodes tumors, offering the first comprehensive analysis of the molecular alterations at work in these tumors.
Daniel F. Hayes, M.D., clinical director of the breast oncology program at the University of Michigan Comprehensive Cancer Center, was elected president of the American Society of Clinical Oncology, the largest and one of the most influential oncology professional societies.
New guidelines based on decades of clinical trials give guidance about which complementary therapies appear to be most effective and safe for breast cancer patients. More than 80 therapies were evaluated and assigned a letter grade.
Donning pink along with the rest of the crowd at the Rockefeller Center plaza in Manhattan and aside former Good Morning America host and breast cancer survivor Joan Lunden, Newman discussed advances in research and treatment.